SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (16996)3/9/1998 9:24:00 PM
From: RXGOLF  Respond to of 32384
 
<<I suspect that the initial cost of setting up the sale of the drug may be higher and/or more complicated than LGND initially expected>>

This is a major concern of mine. I would think that taking a drug to market would be a major hurdle for a "small" pharmaceutical company. My hopes are that Ligands management team has the experience and the pocketbook to sucessfully address this challenge.

Good Luck,
RXGOLF


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News